Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

2 Injured in Crash on Interstate 805 Near 15 Freeway


Victims Hit While Helping Driver Involved in San Diego Accident

San Diego, CA (May 17, 2020) – Two people were injured while helping the victim of a rollover crash in San Diego. The accident occurred on the evening of May 17 on Interstate 805.

A vehicle rolled over on Interstate 805, near the 15 Freeway. Three drivers stopped and ran to help the victim. Another vehicle lost control and hit two of them. The two victims were injured and taken to a local hospital.

#San Diego

#92105


November 8, 2019

1 Killed, 1 Injured in Crash on Roscoe Boulevard

Several Vehicles Involved in Fatal Van Nuys Accident...


January 24, 2020

Qimonni Myers Killed, Layshaun Johnson, Andreuss Brown, Booker Beck, Zoey Hughs Injured in Crash on Highway 99 Near Faith Home Road

Car Hits Concrete Pillar in Fatal Ceres Accident...


December 31, 2019

Man Injured in Bicycle Crash at Bernard and Miller Streets

Victim Suffers Leg Injury in Bakersfield Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.